S&P Futures
4,092.00 +12.00 (+0.29%) Dow Futures
33,113.00 +69.00 (+0.21%) Nasdaq Futures
13,131.00 +49.00 (+0.37%) Russell 2000 Futures
1,785.50 +5.40 (+0.30%) Crude Oil
74.53 +0.16 (+0.22%) Gold
1,998.60 +0.90 (+0.05%)
Revelation Biosciences, Inc. (REVB)
After hours:
- Business Wire
Revelation Biosciences Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2022 and Recent Corporate Progress
SAN DIEGO, March 30, 2023--Revelation Biosciences Inc. (NASDAQ: REVB) (the "Company" or "Revelation"), a life sciences company that is focused on the development of immunologic based therapies for the prevention and treatment of disease, today reported its year end 2022 financial results and highlighted recent corporate progress.
- Business Wire
Revelation Biosciences Inc. Appoints Dr. Julia Bohannon and Dr. Antonio Hernandez to Scientific Advisory Board
SAN DIEGO, March 13, 2023--Revelation Biosciences Inc. (NASDAQ: REVB) (the "Company" or "Revelation"), a life sciences company that is focused on the development of immunologic-based therapies for the prevention and treatment of disease, today announced it has appointed Julia Bohannon, Ph.D. and Antonio Hernandez, M.D. to its scientific advisory board. Dr. Hernandez and Dr. Bohannon are inventors of the phosphorylated hexaacyl disaccharide (PHAD) based technology licensed from Vanderbilt Univers
- Business Wire
Revelation Biosciences Inc. to Participate in a Fireside Chat at the 35th Annual Roth Conference
SAN DIEGO, March 06, 2023--Revelation Biosciences Inc. (NASDAQ: REVB) (the "Company" or "Revelation"), a life sciences company that is focused on the development of immunologic-based therapies for the prevention and treatment of disease, announced today that its Chief Executive Officer James Rolke will participate in a fireside chat at the 35th Annual Roth Conference scheduled for March 12-14, 2023 to be held at The Ritz Carlton, Laguna Niguel in Dana Point, California.
